1
Return

T-type calcium channels regulate medulloblastoma and can be targeted for therapy

delete2025-02-17
delete0
delete
OA
AI
C
Collin Dube
M
Michelle Lai
Y
Ying Zhang
S
Shekhar Saha
U
Ulaş Yener
F
Farina Hanif
K
Kadie Hudson
M
Myron Gibert
P
Pawel Marcinkiewicz
Y
Yunan Sun
T
Tanvika Vegiraju
E
Esther Xu
A
Aditya Sorot
R
Rosa I. Gallagher
J
Julia Wulfkuhle
A
Ashley Vernon
L
Lily Dell’Olio
R
Rajitha Anbu
E
Elizabeth Mulcahy
B
Benjamin Kefas
F
Fadila Guessous
E
Emanuel F. Petricoin
R
Roger Abounader *
DOI:10.1007/s11060-025-04967-5delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
PurposeThe goal of this study was to investigate the role and therapeutic targeting of T-type calcium channels in medulloblastoma, a common and deadly pediatric brain tumor that arises in the cerebellum.MethodsT-type calcium channel expression was assessed in publicly available bulk and single cell RNA-seq datasets. The effects of T-type calcium channel blocker mibefradil on cell growth, death and invasion were assessed with cell counting, alamar blue, trypan blue and transwell assays. Proteomic-based drug target and signaling pathway mapping was performed with Reverse Phase Protein Arrays (RPPA). Co-expression modules of single cell RNA-seq data were generated using high dimensional weighted gene co-expression network analysis (hdWGCNA). Orthotopic xenografts were used for therapeutic studies with the T-Type calcium channel blocker mibefradil.ResultsT-type calcium channels were upregulated in more than 30% of medulloblastoma tumors and patients with high expression associated with a worse prognosis. T-type calcium channels had variable expression across all the subgroups of medulloblastoma at the bulk RNA-seq and single-cell RNA-seq level. Mibefradil treatment or siRNA mediated silencing of T-type calcium channels inhibited tumor cell growth, viability and invasion. RPPA-based protein/phosphoprotein signal pathway activation mapping of T-type calcium channel inhibition and single cell hdWGCNA identified altered cancer signaling pathways. Oral administration of mibefradil inhibited medulloblastoma xenograft growth and prolonged animal survival.ConclusionOur results represent a first comprehensive multi-omic characterization of T-type calcium channels in medulloblastoma and provide preclinical data for repurposing mibefradil as a treatment strategy for these relatively common pediatric brain tumors.
Keywords:
Medulloblastoma
T-type calcium channels
Mibefradil
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

J
Journal of Neuro-Oncology
IF:
3.1
Papers:
8.1K
Citations:
1.5W

Organization

G
George Mason University
Scholars:
7.7K
Papers: 7.9K
Citations: 1.0W
S
Stanford University
Scholars:
9.6W
Papers: 8.2W
Citations: 17.0W
U
University of Virginia
Scholars:
3.0W
Papers: 2.7W
Citations: 4.1W
Cited Papers

Cited Papers

Citing Papers

Citing Papers